Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A

Clinical trial NCT01138501 · COMPLETED

Trial details

NCT number: NCT01138501
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2010-06-01
Primary completion: 2011-11-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.